Abstract
Phase II Study of Avelumab Plus Chemotherapy in the Peri-operative Treatment for Patients With Resectable Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have